Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,749,022
-
Share change
-
+7,749,022
-
Total reported value
-
$26,749,440
-
Price per share
-
$3.44
-
Number of holders
-
14
-
Value change
-
+$26,749,393
-
Number of buys
-
14
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2020
As of 30 Sep 2020,
Summit Therapeutics Inc. - COM (SMMT) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,749,022 shares.
The largest 10 holders included
Polar Capital LLP, JPMORGAN CHASE & CO, BAILLIE GIFFORD & CO, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, UBS Group AG, MIRABELLA FINANCIAL SERVICES LLP, WELLS FARGO & COMPANY/MN, HSBC HOLDINGS PLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.